Key facts
- This page summarizes Spyros Papapetropoulos's Form 4 filing for Vigil Neuroscience, Inc. (VIGL).
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 22 Nov 2022, 20:45.
Spyros Papapetropoulos - 18 Nov 2022 Form 4 Insider Report for Vigil Neuroscience, Inc. (VIGL)
- Reporting relationship
- Chief Medical Officer
- Issuer ticker
- VIGL
- Reported as of
- 18 Nov 2022
- Net transaction value
- -$3,633
- SEC form
- 4
- Accepted by SEC
- 22 Nov 2022, 20:45:28 UTC
- Prior SEC filing
- 10 Jun 2022
- Next SEC filing
- 28 Nov 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ Christopher Verni, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Spyros Papapetropoulos filed Form 4 for Vigil Neuroscience, Inc. (VIGL) on 22 Nov 2022.
Change
- Previous filing in this sequence was filed on 10 Jun 2022.
- Current net transaction value: -$3,633.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
VIGL
transaction
Common Stock
Options Exercise
- Transaction value
- $567
- Shares
- +300
- Change %
- +7.5%
- Price
- $1.89
- Shares after
- 4,300
- Date
- 18 Nov 2022
- Ownership
- Direct
VIGL
transaction
Common Stock
Sale
- Transaction value
- $4,200
- Shares
- -300
- Change %
- -7%
- Price
- $14.00
- Shares after
- 4,000
- Date
- 18 Nov 2022
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
VIGL
transaction
Derivative
Stock Option Grant (Right to Buy)
Options Exercise
- Transaction value
- $0
- Shares
- -300
- Change %
- -0.2%
- Price
- $0.000000
- Shares after
- 149,604
- Date
- 18 Nov 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 300
- Exercise price
- $1.89
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 13, 2022.
Footnote F2
25% of the shares subject to this option vested and became exercisable on September 14, 2021, with the remainder vesting in 36 equal monthly installments thereafter.
SEC remarks
Exhibit 24 - Power of Attorney